Stony Brook University Respiratory Care Program, Stony Brook, New York.
Stony Brook University Medical Center, Pulmonary, Critical Care and Sleep Medicine, Stony Brook, New York.
Respir Care. 2020 Aug;65(8):1077-1089. doi: 10.4187/respcare.07343. Epub 2020 Mar 24.
The present study tested a novel nebulizer and circuit that use breath enhancement and breath actuation to minimize ventilator influences. The unique circuit design incorporates "wet-side" jet nebulization (the nebulizer connected to the humidifier outlet port) to prevent unpredictable aerosol losses with active humidification. The system was studied using several ventilator brands over a wide range of settings, with and without humidification.
During treatment, a 2-position valve directed all ventilator flow to the nebulizer, providing breath enhancement during inspiration. Aerosol was generated by air 50 psi 3.5 L/m triggered during inspiration by a pressure-sensitive circuit. Particles were captured on an inhaled mass filter. Testing was performed by using active humidification or bypassable valved heat and moisture exchanger (HME) over a range of breathing patterns, ventilator modes, and bias flows (0.5-5.0 L/m). The nebulizer was charged with 6 mL of radiolabeled saline solution. Mass balance was performed by using a gamma camera. Tidal volume was monitored by ventilator volume (exhaled V) and test lung volume. The Mann-Whitney test was used.
A total of 6 mL was nebulized within 1 h. Inhaled mass (% neb charge): mean ± SD (all data) 31.1% ± 6.45; no. 83. Small significant differences were seen with humidification for all modes (humidified 36.1% ± 5.60, no. 26; bypassable valved HME 28.8% ± 5.51, no. 57 [ < .001]), continuous mandatory ventilation modes [ < .001], and pressure support airway pressure release ventilation modes [ < .001]. Mass median aerodynamic diameter ranged from 1.04 to 1.34 μm. The V was unaffected (exhaled V -5.0 ± 12.9 mL; = .75) and test lung (test lung volume 25 ± 14.5 mL; = .13). Bias flow and PEEP had no effect.
Breath enhancement with breath actuation provided a predictable dose at any ventilator setting or type of humidification. Preservation of drug delivery during active humidification is a new finding, compared with previous studies. The use of wall gases and stand alone breath actuation standardizes conditions that drive the nebulizer independent of ventilator design. Wet-side nebulizer placement at the humidifier outlet allows delivery without introducing aerosol into the humidification chamber.
本研究测试了一种新型的雾化器和回路,该系统利用呼吸增强和呼吸触发来最大程度地减少呼吸机的影响。独特的回路设计采用了“湿侧”射流雾化(将雾化器连接到加湿器出口端口),以防止主动加湿时不可预测的气溶胶损失。该系统在多种呼吸机品牌上进行了研究,范围广泛,包括加湿和不加湿两种情况。
在治疗过程中,一个 2 位阀将所有呼吸机流量引导至雾化器,在吸气时提供呼吸增强。通过压力敏感回路在吸气时触发 50 psi(3.5 L/m)的空气来产生气溶胶。颗粒被吸入质量过滤器捕获。通过使用主动加湿或可旁路阀式热和湿气交换器(HME),在各种呼吸模式、呼吸机模式和偏流(0.5-5.0 L/m)下进行测试。将 6 毫升放射性标记的生理盐水注入雾化器。通过伽马相机进行质量平衡。通过呼吸机体积(呼出 V)和测试肺体积监测潮气量。使用 Mann-Whitney 检验。
在 1 小时内总共雾化了 6 毫升。吸入质量(%雾化剂量):平均值 ± 标准差(所有数据)31.1% ± 6.45;n = 83。加湿时,所有模式(加湿 36.1% ± 5.60,n = 26;可旁路阀式 HME 28.8% ± 5.51,n = 57)均出现显著差异(<.001),连续强制通气模式(<.001)和压力支持气道压力释放通气模式(<.001)。质量中值空气动力学直径范围为 1.04 至 1.34μm。V 不受影响(呼出 V -5.0 ± 12.9 毫升; =.75),测试肺(测试肺体积 25 ± 14.5 毫升; =.13)。偏流和 PEEP 没有影响。
呼吸触发的呼吸增强在任何呼吸机设置或加湿类型下都能提供可预测的剂量。与之前的研究相比,在主动加湿过程中保持药物输送是一个新发现。使用壁气和独立的呼吸触发使驱动雾化器的条件标准化,而与呼吸机设计无关。将湿侧雾化器放置在加湿器出口处可在不将气溶胶引入加湿器腔室的情况下进行输送。